Lin Wang
- Biomaterials top 0.1%
- Silk-based biomaterials and applications 37
- Electrospun Nanofibers in Biomedical Applications 36
- Cancer Research top 0.2%
- MicroRNA in disease regulation 62
- Cancer-related molecular mechanisms research 57
- Cancer, Hypoxia, and Metabolism 30
- Immunology top 0.5%
- Obstetrics and Gynecology top 0.5%
- Molecular Biology top 0.2%
- Circular RNAs in diseases 33
- RNA Interference and Gene Delivery 32
-
- Nanoplatforms for cancer theranostics 49
Lin Wang
862 papers receiving 27.6k citations
Hit Papers
Peers
Comparison fields: 5 of 208
- Biomaterials 3.6k
- Cancer Research 3.9k
- Immunology 3.4k
- Obstetrics and Gynecology 1.3k
- Molecular Biology 9.9k
Countries citing papers authored by Lin Wang
This map shows the geographic impact of Lin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Wang more than expected).
Fields of papers citing papers by Lin Wang
This network shows the impact of papers produced by Lin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Wang. The network helps show where Lin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 10 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 26 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 41 | |
| 14 | 2021 | 29 | |
| 15 | 2020 | 2 | |
| 16 | 2020 | 57 | |
| 17 | 2016 | 85 | |
| 18 | 2015 | 64 | |
| 19 | 2014 | 42 | |
| 20 | 2013 | 63 |
About Lin Wang
Lin Wang is a scholar working on Cancer Research, Biomaterials and Oncology, having authored 896 papers that have together received 28.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (62 papers), Cancer-related molecular mechanisms research (57 papers), Nanoplatforms for cancer theranostics (49 papers), Silk-based biomaterials and applications (37 papers), Electrospun Nanofibers in Biomedical Applications (36 papers), Circular RNAs in diseases (33 papers), RNA Interference and Gene Delivery (32 papers) and Cancer, Hypoxia, and Metabolism (30 papers). The work is most often cited by research in Biomaterials (3.6k citations), Cancer Research (3.9k citations) and Immunology (3.4k citations). Lin Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zheng Wang, Guobin Wang, Saravana K. Ramasamy, Anjali P. Kusumbe, Ralf H. Adams, Guowen Zhang, Jia Liu, Luming Xu, Shiwen Xia and Lianhong Zhang. Their work appears in journals such as PLoS ONE, ACS Applied Materials & Interfaces, Scientific Reports, Advanced Science and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.